- Report
- August 2025
- 186 Pages
Global
From €3127EUR$3,545USD£2,707GBP
€3474EUR$3,939USD£3,007GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,129GBP
- Report
- November 2023
- 171 Pages
Global
From €2205EUR$2,500USD£1,909GBP
The Neuropathy Pain Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neuropathy Pain Drugs are used to treat the pain associated with peripheral neuropathy, a condition caused by damage to the peripheral nervous system. These drugs are typically prescribed to patients with diabetes, HIV, and chemotherapy-induced neuropathy. Commonly prescribed Neuropathy Pain Drugs include anticonvulsants, antidepressants, and opioids.
The Neuropathy Pain Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Johnson & Johnson, and Merck & Co. Other companies in the market include AbbVie, AstraZeneca, Eli Lilly, and Teva Pharmaceuticals. Show Less Read more